Clinical Trial

Evaluation of the Efficacy and Safety of Stiripentol in Patients 6 Years and Older With Primary Hyperoxaluria Type 1, 2 or 3

Name: Evaluation of the Efficacy and Safety of Stiripentol in Patients 6 Years and Older With Primary Hyperoxaluria Type 1, 2 or 3 — clinical trial record (NCT06465472)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CRYSTAL

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

Evaluation of the efficacy and safety of stiripentol in patients 6 years and older with primary hyperoxaluria type 1, 2 or 3.

Trial Details

NCT Number	NCT06465472
Lead Sponsor	Biocodex Collaborators: Exystat
Conditions	Primary Hyperoxaluria Type 1, Primary Hyperoxaluria Type 2, Primary Hyperoxaluria Type 3
Enrollment	42 participants
Start Date	2024-08
Primary Completion	2030-08 (estimated)
Study Completion	2030-08 (estimated)
Updated on ClinicalTrials.gov	2024-06-18